Predictive value of a CLIA-approved organoid based drug sensitivity test.Astrid Margossian, Carla Grandori, Kathleen Motamedi et al.|Journal of Clinical Oncology|2020Cited by 6
A cancer organogram test as a guide for oncology treatments in SOLID tumors: An analysis of 628 tests in 419 patients.Astrid Margossian, Carla Grandori, Madison Pollastro et al.|Journal of Clinical Oncology|2021Cited by 4
Abstract 818: Organoid based functional test to predict personalized treatment in cholangiocarcinomaAstrid Margossian, Carla Grandori, Franz X. Schaub et al.|Cancer Research|2020Cited by 2
Association between ex vivo pharmacotyping of patient-derived tumor organoids and personalized therapeutic options for patients with biliary tract cancer.Payel Chatterjee, Carla Grandori, Annie Richardson et al.|Journal of Clinical Oncology|2025Cited by 1